tiprankstipranks
Advertisement
Advertisement

HK:0512 Stock Latest News

Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime
Company AnnouncementsGrand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime
13d ago
0512
Grand Pharmaceutical Sets 2026 AGM, Proposes Dividend and New Share Mandate
PremiumCompany Announcements
Grand Pharmaceutical Sets 2026 AGM, Proposes Dividend and New Share Mandate
13d ago
0512
Grand Pharmaceutical Bolsters Liver Cancer Portfolio as Y-90 Trial Hits Key Endpoint in U.S.
PremiumCompany Announcements
Grand Pharmaceutical Bolsters Liver Cancer Portfolio as Y-90 Trial Hits Key Endpoint in U.S.
29d ago
0512
Grand Pharmaceutical Deepens HKU Ties as 2026 Innovation Pipeline Takes Shape
PremiumCompany Announcements
Grand Pharmaceutical Deepens HKU Ties as 2026 Innovation Pipeline Takes Shape
1M ago
0512
Grand Pharmaceutical Lifts Revenue, Boosts Innovative Mix Amid Margin Pressure
PremiumCompany Announcements
Grand Pharmaceutical Lifts Revenue, Boosts Innovative Mix Amid Margin Pressure
2M ago
0512
Grand Pharmaceutical Declares Final HKD 0.169 Dividend for 2025
PremiumCompany AnnouncementsGrand Pharmaceutical Declares Final HKD 0.169 Dividend for 2025
2M ago
0512
Grand Pharmaceutical Wins China Phase II Trial Nod for Innovative Migraine TCM
Premium
Company Announcements
Grand Pharmaceutical Wins China Phase II Trial Nod for Innovative Migraine TCM
2M ago
0512
Grand Pharmaceutical Wins China’s First Approval for Demodex Blepharitis Drug, Bolstering Ophthalmic Push
Premium
Company Announcements
Grand Pharmaceutical Wins China’s First Approval for Demodex Blepharitis Drug, Bolstering Ophthalmic Push
2M ago
0512
Grand Pharmaceutical Warns of 2025 Profit Slump as It Accelerates Shift to Innovative Drugs
PremiumCompany Announcements
Grand Pharmaceutical Warns of 2025 Profit Slump as It Accelerates Shift to Innovative Drugs
2M ago
0512
Grand Pharmaceutical Secures HK$0.8 Billion Loan Tied to Ownership Stability
PremiumCompany Announcements
Grand Pharmaceutical Secures HK$0.8 Billion Loan Tied to Ownership Stability
2M ago
0512
Grand Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results and Final Dividend
PremiumCompany Announcements
Grand Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results and Final Dividend
2M ago
0512
Grand Pharmaceutical Clarifies Valuation Basis for RMB316 Million API Assets Acquisition
PremiumCompany Announcements
Grand Pharmaceutical Clarifies Valuation Basis for RMB316 Million API Assets Acquisition
3M ago
0512
Grand Pharmaceutical Wins NMPA Acceptance for Prostate Cancer Imaging Drug TLX591-CDx
PremiumCompany AnnouncementsGrand Pharmaceutical Wins NMPA Acceptance for Prostate Cancer Imaging Drug TLX591-CDx
4M ago
0512
Grand Pharmaceutical to Acquire Two Biotech and Fine Chemical Units in RMB316 Million Connected Deal
Premium
Company Announcements
Grand Pharmaceutical to Acquire Two Biotech and Fine Chemical Units in RMB316 Million Connected Deal
4M ago
0512
Grand Pharmaceutical Wins China Nod for World’s First Adrenaline Nasal Spray
Premium
Company Announcements
Grand Pharmaceutical Wins China Nod for World’s First Adrenaline Nasal Spray
4M ago
0512
Grand Pharmaceutical Secures China Rights to World’s First Adrenaline Nasal Spray
PremiumCompany Announcements
Grand Pharmaceutical Secures China Rights to World’s First Adrenaline Nasal Spray
5M ago
0512
Grand Pharmaceutical’s TLX591-CDx Hits Phase III Goal in China, Bolstering Nuclear Medicine Push
PremiumCompany Announcements
Grand Pharmaceutical’s TLX591-CDx Hits Phase III Goal in China, Bolstering Nuclear Medicine Push
5M ago
0512
Grand Pharmaceutical’s GPN01530 Gains FDA Approval for Clinical Trials
PremiumCompany Announcements
Grand Pharmaceutical’s GPN01530 Gains FDA Approval for Clinical Trials
5M ago
0512
Grand Pharmaceutical’s TCM for Depression Achieves Clinical Milestone
PremiumCompany Announcements
Grand Pharmaceutical’s TCM for Depression Achieves Clinical Milestone
5M ago
0512
Grand Pharmaceutical Updates Directors’ Emoluments in Annual Reports
PremiumCompany AnnouncementsGrand Pharmaceutical Updates Directors’ Emoluments in Annual Reports
5M ago
0512
Glenmark Pharmaceutical’s Ryaltris® Nasal Spray Approved for Chinese Market
Premium
Company Announcements
Glenmark Pharmaceutical’s Ryaltris® Nasal Spray Approved for Chinese Market
6M ago
0512
Glenmark Pharmaceutical’s Ryaltris® Nasal Spray Approved for Chinese Market
Premium
Company Announcements
Glenmark Pharmaceutical’s Ryaltris® Nasal Spray Approved for Chinese Market
6M ago
0512

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >